LascoÑa, Larre Mae .
HRN: 26-42-37 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2024
CEFTRIAXONE 1G (VIAL)
12/25/2024
12/31/2024
IV
400mg
Q12
PCAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes